NZ-based Izon inks US distribution deal
Nanotechnology company Izon Science has signed a distribution agreement with US based BridgePath Scientific.
The agreement will see BridgePath Scientific distribute Izon's nanoparticle analysis systems on a non-exclusive basis in the US.
"BridgePath has an extensive network of scientific researchers around the country and they're known for their reliability, responsiveness and forward thinking. We're very pleased to be working with Patrick and his team to increase the uptake of our technology into the US. This is a very important relationship for us", said Hans van der Voorn, Executive Chairman of Izon.
Izon says its qNano and qViro instruments provide the world's most comprehensive nanoparticle analysis system in a single instrument.
Patrick Haley, BridgePath's Chief Executive added, “We look forward to representing Izon Science in the US and adding Izon's instruments to our existing scientific research product range. Izon's new analytical tools will help researchers conduct novel research in a number of nanoparticle related fields."
